reglab/statecodes huggingface dataset:
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Animal Rabies › Section 441A.433 - Animal shelter required to provide for vaccination of dog, cat or ferret released for adoption

Current through June 11, 2024
1. Before releasing
				a dog, cat or ferret for adoption, an animal shelter shall:
(a) Have the dog, cat or ferret vaccinated
				against rabies in the manner prescribed in NAC 441A.435 and provide the person
				who adopts the dog, cat or ferret with a certificate of vaccination issued
				pursuant to NAC 441A.440; or
(b)
				Issue to the person who adopts the dog, cat or ferret a voucher which can be
				presented to a licensed veterinarian as payment for the vaccination of the dog,
				cat or ferret.
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Animal Rabies › Section 441A.440 - Veterinarians: Issuance of certificates of vaccination and rabies vaccination tags; cooperation with investigation by rabies control authority

Current through June 11, 2024
1. A veterinarian who vaccinates an animal
				against rabies shall complete three copies of a certificate of vaccination
				against rabies for the animal vaccinated. The certificate of vaccination
				against rabies must include, but is not limited to:
(a) The name and address of the owner of the
				animal.
(b) A description of the
				animal, including the name, age, sex, breed, color and weight of the
				animal.
(c) The date the
				vaccination was administered.
(d)
				The product name of the vaccine used.
(e) The lot number of the vaccine.
(f) The date the animal is due for
				revaccination based on the duration of immunity provided by the vaccine
				according to its label.
(g) The
				number on the rabies vaccination tag issued pursuant to subsection 3.
(h) The name, address and license number of
				the veterinarian.
(i) The signature
				of the veterinarian who administered the vaccine. The signature may be
				handwritten, stamped or produced by a computer.
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Animal Rabies › Section 441A.445 - Prohibited activities on private property involving bat, skunk, raccoon, fox or coyote; relinquishment of animal; exemptions

Current through June 11, 2024
1.
				Except as otherwise provided in subsection 2:
(a) A person shall not intentionally keep,
				harbor or in any way care for, maintain, lodge or feed on private property, a
				bat, skunk, raccoon, fox or coyote.
(b) Any person violating the provisions of
				paragraph (a) of this subsection shall, upon request of the rabies control
				authority and the Department of Wildlife, relinquish the animal to the rabies
				control authority or the Department.
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.450 - Acquired immune deficiency syndrome (AIDS); human immunodeficiency virus infection (HIV)

Current through June 11, 2024
1. The health
				authority shall investigate each report of a case having a human
				immunodeficiency virus infection (HIV), as identified by a confirmed positive
				human immunodeficiency virus infection (HIV) blood test administered by a
				medical laboratory, to confirm the diagnosis and identify each person with whom
				the case has had sexual relations and each person with whom the case has shared
				a needle. The health authority shall notify each person so identified of his or
				her potential exposure and of the availability of counseling and of testing for
				the presence of human immunodeficiency virus infection (HIV). If a person
				notified pursuant to this section is unable to obtain counseling as set forth
				in NRS
				441A.336, the health authority shall provide,
				or ensure the provision of, the counseling.
2. If a case reported pursuant to subsection
				1 has donated or sold blood, plasma, sperm or other bodily tissues during the
				year preceding the diagnosis, the health authority shall make reasonable
				efforts to notify the recipient of his or her potential exposure to the human
				immunodeficiency virus infection (HIV).
3. If a case is reported pursuant to
				subsection 1 because of a sexual offense, the health authority shall seek the
				identity and location of the victim and make reasonable efforts to notify the
				victim of his or her possible exposure and to advise him or her of the
				availability of counseling and testing for human immunodeficiency virus
				infection (HIV).
4. If a case
				reported pursuant to subsection 1 has active tuberculosis or tuberculosis
				infection, the health authority shall make reasonable efforts to ensure that
				appropriate remedial and medical treatment of the tuberculosis or infection is
				provided.
5. If, at any time, a
				case reported pursuant to subsection 1 requests assistance from the health
				authority for notifying and counseling persons with whom the case has had
				sexual relations or persons with whom the case has shared a needle, the health
				authority shall provide that service.
6. If a case reported pursuant to subsection
				1 is in a medical facility, the medical facility shall provide care to the case
				in accordance with blood and body fluid precautions and, if another
				communicable disease is present, universal precautions or the appropriate
				disease specific precautions.
Added to NAC by Bd. of
				  Health, eff. 1-24-92; A by R087-08, 1-13-2011; A by
				  R148-22A,
				  eff. 7/26/2023; A by
				  R002-22A,
				  eff. 9/18/2023
NRS 439.200,
					 441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.455 - Amebiasis

Current through June 11, 2024
1. The health authority shall investigate
				each report of a case having amebiasis to confirm the diagnosis, to identify
				any contacts, to identify the source of infection, to determine if the case is
				employed in a sensitive occupation or is a child attending a child care
				facility and to determine if there is any contact residing in the same
				household as the case who is employed in a sensitive occupation.
2. Except as otherwise provided in this
				subsection, a person excreting Entamoeba histolytica shall not work in a
				sensitive occupation unless authorized to do so by the health authority. A
				person excreting
Entamoeba histolytica
may work in a sensitive
				occupation if:
(a) An effective antiparasitic
				regimen has been completed by the person and has been confirmed by his or her
				health care provider;
(b) Three
				fecal specimens that are collected from the person at least 24 hours apart and
				at least 48 hours after cessation of antiparasitic therapy fail to show
Entamoeba histolytica
organisms upon testing by a medical
				laboratory or the person receives a negative result on an antigen test that is
				approved by the Food and Drug Administration of the United States Department of
				Health and Human Services for the detection of Entamoeba histolytica;
(c) The person is asymptomatic and
				there is no indication of poor personal hygiene; or
(d) The employer of the person would be
				prohibited from preventing the person from engaging in that occupation by the
				Americans with Disabilities Act of 1990,
				42 U.S.C. §§
											12101 et seq., or
				NRS
				613.330.
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.460 - Anthrax

Current through June 11, 2024
1. The health authority shall investigate
				each report of a case having anthrax or suspected case considered to have
				anthrax to confirm the diagnosis, to determine the extent of any outbreak of
				the infection and to identify the source of infection.
2. The health authority shall notify the
				State Health Officer if the source of infection is suspected to be
				occupational. The State Health Officer shall notify the appropriate regulatory
				agency of any suspected occupational exposure.
3. The health authority shall notify the
				State Health Officer if the source of infection is suspected to be an infected
				animal. The State Health Officer shall notify the Administrator of the Division
				of Animal Industry of the State Department of Agriculture (State Veterinarian),
				who shall immediately investigate the report and shall carry out necessary
				measures for the prevention, suppression and control of the transmission of the
				disease from animals to humans.
4.
				The health authority shall notify the State Health Officer if the source of
				infection is known or suspected to be related to an act of intentional
				transmission or biological terrorism.
5. If a case having anthrax is in a medical
				facility, the medical facility shall provide care to the case in accordance
				with drainage and secretion precautions or other appropriate disease specific
				precautions.
Added to NAC by Bd. of
				  Health, eff. 1-24-92; A by R087-08, 1-13-2011
NRS
					 441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.465 - Botulism

Current through June 11, 2024
1. The health authority shall investigate
				each report of a case having botulism or suspected case considered to have
				botulism to confirm the diagnosis, to identify the source of intoxication, to
				identify other exposed persons and to obtain and submit environmental samples
				for laboratory testing.
2. If the
				source of intoxication is foodborne, the health authority shall properly
				dispose of contaminated food and utensils in order to prevent further ingestion
				of the contaminated food or other contact of the toxin with a person or
				animal.
3. If the case having
				botulism is an infant, the health authority shall search for other cases to
				determine whether to rule out foodborne botulism.
4. The health authority shall notify the
				State Health Officer if the source of intoxication is known or suspected to be
				related to an act of intentional transmission or biological
				terrorism.
5. As used in this
				section, "botulism" includes, without limitation, foodborne botulism, infant
				botulism, wound botulism, and botulism, other than foodborne botulism, infant
				botulism or wound botulism.
Added to NAC by Bd. of
				  Health, eff. 1-24-92; A by R087-08, 1-13-2011
NRS
					 441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.475 - Brucellosis

Current through June 11, 2024
1. The health authority shall investigate
				each report of a case having brucellosis to confirm the diagnosis and to
				identify the source of infection.
2. The health authority shall notify the
				State Health Officer if the source of infection is suspected to be an infected
				animal. The State Health Officer shall notify the Administrator of the Division
				of Animal Industry of the State Department of Agriculture (State Veterinarian)
				who shall immediately investigate the report and shall take all necessary
				measures for the prevention, suppression and control of the disease in
				animals.
3. The health authority
				shall notify the State Health Officer if the source of infection is suspected
				to be occupational. The State Health Officer shall notify the appropriate
				regulatory agency of any suspected occupational exposure.
Added to NAC by Bd. of
				  Health, eff. 1-24-92
NRS
					 441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.480 - Campylobacteriosis

Current through June 11, 2024
1. The health authority shall investigate
				each report of a case having campylobacteriosis to confirm the diagnosis, to
				identify the source of infection and to determine if the case is employed in a
				sensitive occupation or is a child attending a child care facility.
2. A person excreting
Campylobacter
spp. shall not work in a sensitive occupation
				until authorized to do so by the health authority, unless the employer of the
				person would be prohibited from preventing the person from engaging in that
				occupation by the Americans with Disabilities Act of 1990,
				42 U.S.C. §§
										12101 et seq., or
				NRS
				613.330. The health authority may authorize a
				person excreting
Campylobacter
spp. to work in a sensitive
				occupation if:
(a) At least two fecal
				specimens, which are collected from the case at least 24 hours apart and at
				least 48 hours after cessation of antimicrobial therapy, fail to show
Campylobacter
spp. organisms upon testing by a medical
				laboratory; or
(b) If the case is
				asymptomatic and there is no indication of poor personal hygiene.
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.482 - Carbapenem-resistant Enterobacteriaceae

Current through June 11, 2024
1. The health
				authority shall, within the limits of available resources, investigate each
				report of a case having carbapenem-resistant Enterobacteriaceae, as determined
				in accordance with "Carbapenemase Producing Carbapenem-Resistant
				Enterobacteriaceae (CP-CRE) 2018 Case Definition," adopted by reference in NAC
				441A.200, to:
(a) Confirm the diagnosis;
(b) Determine the extent of any
				outbreak;
(c) Identify, categorize
				and evaluate contacts; and
(d)
				Evaluate the efficacy of any precautions concerning contacts, disease-specific
				precautions or other precautions for the control of the infection that are in
				effect.
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.485 - Chancroid

Current through June 11, 2024
1. The health authority shall investigate
				each report of a case having chancroid to confirm the diagnosis, to determine
				the source or possible source of the infection and to ensure that the case and
				any contacts have received appropriate testing and medical treatment.
2. Except as otherwise provided in
				NRS
				441A.210, a person having chancroid shall
				obtain medical treatment for the disease.
3. The health care provider for a person
				having chancroid shall notify the health authority immediately if the person
				fails to obtain medical treatment or fails to complete the prescribed course of
				medical treatment. Except as otherwise provided in
				NRS
				441A.210, the health authority shall take
				action to ensure that the person receives appropriate medical treatment for the
				disease.
4. A clinic, dispensary or
				health care provider that accepts supplies or aid from the Division shall
				provide counseling and take such measures for the testing, treatment,
				prevention, suppression and control of chancroid as are specified in "Sexually
				Transmitted Infections Treatment Guidelines, 2021," adopted by reference
				pursuant to NAC
				441A.200.
5. A health care provider shall follow the
				procedures set forth in "Sexually Transmitted Infections Treatment Guidelines,
				2021," adopted by reference pursuant to NAC
				441A.200, when testing and
				treating persons with chancroid.
Added to NAC by Bd. of
				  Health, eff. 1-24-92; A by R087-08, 1-13-2011; A by
				  R148-22A,
				  eff. 7/26/2023; A by
				  R002-22A,
				  eff. 9/18/2023
NRS 439.200,
					 441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.487 - Chikungunya virus disease

Current through June 11, 2024
The health authority shall investigate each report of a case
				  having chikungunya virus disease to:
1. Confirm the diagnosis;
2. Search for other cases; and
3. Determine the need for measures to
				prevent, suppress or control the spread of the infection.
Added to
				  NAC by Bd. of Health by
				  R187-18A,
				  eff. 6/26/2019
NRS
				  439.200 and
				  441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.490 - Chlamydia trachomatis infection

Current through June 11, 2024
1. The health
				authority shall investigate each report of a case having
Chlamydia
				trachomatis
infection of the genital tract to confirm the diagnosis,
				to determine the source or possible source of the infection and to ensure that
				the case and any contacts have received appropriate testing and medical
				treatment for the infection.
2.
				Except as otherwise provided in
				NRS
				441A.210, a person with
Chlamydia
				trachomatis
infection shall obtain medical treatment for the
				infection.
3. The health care
				provider for a person with
Chlamydia trachomatis
infection
				shall notify the health authority immediately if the person fails to obtain
				medical treatment or fails to complete the prescribed course of medical
				treatment. Except as otherwise provided in NRS 441A. 210, the health authority
				shall take action to ensure that the person receives appropriate medical
				treatment for the infection.
4. A
				clinic, dispensary or health care provider that accepts supplies or aid from
				the Division shall provide counseling and take such measures for the testing,
				treatment, prevention, suppression and control of
Chlamydia
				trachomatis
infection as are specified in "Sexually Transmitted
				Infections Treatment Guidelines, 2021," adopted by reference pursuant to NAC
				441A.200.
5. A health care provider shall follow the
				procedures set forth in "Sexually Transmitted Infections Treatment Guidelines,
				2021," adopted by reference pursuant to NAC
				441A.200, when testing and
				treating persons with
Chlamydia trachomatis
infection.
6. If a case having
Chlamydia trachomatis
infection of the genital tract is in a
				medical facility, the medical facility shall provide care to the case in
				accordance with drainage and secretion precautions or other appropriate disease
				specific precautions.
Added to NAC by Bd. of
				  Health, eff. 1-24-92; A by R087-08, 1-13-2011; A by
				  R148-22A,
				  eff. 7/26/2023; A by
				  R002-22A,
				  eff. 9/18/2023
NRS 439.200,
					 441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.495 - Cholera

Current through June 11, 2024
1. The health authority shall investigate
				each report of a case having cholera to confirm the diagnosis, to determine the
				extent of any outbreak, to identify any carriers or contacts, to identify the
				source of infection, to determine if the case is employed in a sensitive
				occupation or is a child attending a child care facility and to determine if
				there is a contact residing in the same household as the case who is employed
				in a sensitive occupation.
2. A
				person excreting
Vibrio cholerae
shall not work in a sensitive
				occupation until authorized to do so by the health authority, unless the
				employer of the person would be prohibited from preventing the person from
				engaging in that occupation by the Americans with Disabilities Act of 1990,
				42 U.S.C. §§
										12101 et seq., or
				NRS
				613.330. The health authority may authorize a
				case who is excreting
Vibrio cholerae
to work in a sensitive
				occupation if:
(a) At least two fecal
				specimens, which are collected from the case at least 24 hours apart and at
				least 48 hours after cessation of antimicrobial therapy, fail to show
Vibrio cholerae
organisms upon testing by a medical
				laboratory; and
(b) The person is
				asymptomatic.
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.500 - Coccidioidomycosis

Current through June 11, 2024
1. The health authority shall confirm each
				reported case having coccidioidomycosis identified by histopathological
				evidence, by the isolation and identification of fungus in clinical specimens,
				by demonstration of a specific serologic response in acute and convalescent
				sera, or by a positive precipitin test in combination with a compatible
				clinical syndrome. The health authority shall obtain sufficient information
				about each case for the purpose of surveillance.
2. When an association is suspected among two
				or more cases described in subsection 1, the health authority shall conduct an
				investigation to determine whether there is a common source of
				infection.
Added to NAC by Bd. of
				  Health, eff. 1-24-92
NRS
					 441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.505 - Cryptosporidiosis

Current through June 11, 2024
1. The health authority shall investigate
				each report of a case having cryptosporidiosis, identified by the detection of
				Cryptosporidium organisms or DNA in stool, intestinal samples, biopsy specimens
				or other biological samples upon testing by a medical laboratory, to:
(a) Confirm the diagnosis;
(b) Identify any contacts;
(c) Identify the source of
				infection;
(d) Determine if the
				case is employed in a sensitive occupation or is a child attending a child care
				facility; and
(e) Determine if
				there is a contact residing in the same household as the case who is employed
				in a sensitive occupation.
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.508 - Dengue

Current through June 11, 2024
The health authority shall investigate each report of a case
				  having dengue to:
1. Confirm the
				diagnosis;
2. Search for other
				cases; and
3. Determine the need
				for measures to prevent, suppress or control the spread of the
				infection.
Added to
				  NAC by Bd. of Health by
				  R187-18A,
				  eff. 6/26/2019
NRS
				  439.200 and
				  441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.510 - Diphtheria

Current through June 11, 2024
1. The health authority shall investigate
				each report of a case having diphtheria or suspected case considered to have
				diphtheria to determine if the isolated organism is a toxigenic strain of
Corynebacterium diphtheriae
, to determine the extent of any
				outbreak, to identify any carriers or contacts and to identify the source of
				the infection.
2. If a case having
				oropharyngeal toxigenic diphtheria or a suspected case considered to have
				oropharyngeal toxigenic diphtheria is in a medical facility, the medical
				facility shall provide care to the case or suspected case in accordance with
				procedures of strict isolation and other appropriate disease specific
				precautions. The health authority having jurisdiction where the medical
				facility is located may waive the requirement of isolation if two specimens
				from the nose and two specimens from the throat, taken from the case or
				suspected case at least 24 hours apart and at least 24 hours after cessation of
				antibiotic therapy, fail to show toxigenic
Corynebacterium
				diphtheriae
organisms upon testing by a medical laboratory.
3. If a case having cutaneous toxigenic
				diphtheria or a suspected case considered to have cutaneous toxigenic
				diphtheria is in a medical facility, the medical facility shall require contact
				isolation of the case or suspected case or provide care to the case or
				suspected case in accordance with the appropriate disease specific precautions.
				The health authority having jurisdiction where the medical facility is located
				may waive the requirement of isolation after two specimens from the wound of
				the case or suspected case fail to show toxigenic
Corynebacterium
				diphtheriae
organisms upon testing by a medical laboratory.
4. The health authority shall offer
				immunization against diphtheria to any contacts of a case, suspected case or
				carrier of diphtheria.
5. A contact
				of a case, suspected case or carrier of diphtheria shall not work in a
				sensitive occupation, unless the employer of the case, suspected case or
				carrier would be prohibited from preventing the case, suspected case or carrier
				from engaging in that occupation by the Americans with Disabilities Act of
				1990, 42 U.S.C. §§
										12101 et seq., or
				NRS
				613.330 or it has been determined that the
				contact is not a carrier by a health care provider by means of testing a
				nasopharyngeal specimen or a specimen from another site suspected to be
				infected. The health authority may waive this restriction.
Added to NAC by Bd. of
				  Health, eff. 1-24-92; A by
				  R148-22A,
				  eff. 7/26/2023
NRS 439.200,
					 441A.120,
					 441A.180
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.512 - Ehrlichiosis/anaplasmosis

Current through June 11, 2024
The health authority shall investigate each report of a case
				  having ehrlichiosis/anaplasmosis to:
1. Confirm the diagnosis; and
2. Determine the geographic location where
				the exposure to the disease occurred.
Added to NAC by Bd. of
				  Health by R087-08, eff. 1-13-2011
NRS
					 441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.515 - Enterohemorrhagic E. coli

Current through June 11, 2024
1. The health
				authority shall investigate each report of:
(a) A case having Shiga toxin-producing
Escherichia
coli , as identified by clinical specimens that
				demonstrate the presence of Shiga toxin-producing
Escherichia
coli or specific toxins upon testing by a medical laboratory; and
(b) A suspected case considered to have Shiga
				toxin-producing
Escherichia
coli , as identified by the
				presence of hemorrhagic diarrhea or hemolytic-uremic syndrome, and from whom
				clinical specimens have not been tested.
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.520 - Encephalitis

Current through June 11, 2024
1. A report to the health authority of a case
				having encephalitis (arthropod-borne and unspecified viral) must include the
				specific viral, bacterial, fungal or parasitic cause of the disease if
				known.
2. The health authority
				shall investigate each report of a case of encephalitis (arthropod-borne and
				unspecified viral) to confirm the diagnosis and to search for other
				cases.
3. If an association is
				suspected among two or more cases having encephalitis (arthropod-borne and
				unspecified viral), the health authority shall conduct an investigation to
				determine whether there is an existence of a common source of
				infection.
4. If a health authority
				identifies a common source of infection and determines that the common source
				of infection is a threat to the general welfare of the community, the health
				authority shall inform the public of the common source of infection and shall
				provide education on the risk, transmission, prevention and control of
				encephalitis.
5. If a case having
				encephalitis is in a medical facility, the medical facility shall provide care
				to the case in accordance with enteric precautions or other appropriate disease
				specific precautions for the duration of the illness or for 7 days after the
				onset of the illness, whichever period is longer.
Added to NAC by Bd. of
				  Health, eff. 1-24-92
NRS
					 441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.525 - Extraordinary occurrence of illness

Current through June 11, 2024
1. The health
				authority shall investigate each report of a case having an extraordinary
				occurrence of illness or suspected case considered to have an extraordinary
				occurrence of illness to confirm the diagnosis, to determine the extent of any
				outbreak, to identify the source of infection or illness, to determine if there
				is a risk to the health or welfare of the public and to determine if management
				by a public health agency is feasible.
2. The health authority shall carry out the
				investigation and measures for the prevention and control of the extraordinary
				occurrence of illness in consultation with the Chief Medical Officer and any
				guidance issued by the Centers for Disease Control and Prevention relating to
				the detection and mitigation of and response to the extraordinary occurrence of
				illness. The Chief Medical Officer may investigate an extraordinary occurrence
				of illness by conducting a special study.
3. The health authority shall notify the
				Chief Medical Officer if the source of infection or illness is known or
				suspected to be related to an act of intentional transmission or biological
				terrorism.
Added to NAC by Bd. of
				  Health, eff. 1-24-92; A by R087-08, 1-13-2011; A by
				  R148-22A,
				  eff. 7/26/2023
NRS 439.200,
					 441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.530 - Foodborne disease outbreak

Current through June 11, 2024
1. The health
				authority shall investigate each report of an outbreak or suspected outbreak of
				illness known or suspected to be caused by a contaminated food or
				beverage.
2. The health authority
				shall conduct an epidemiological investigation of each report of an outbreak or
				suspected outbreak to confirm its existence, to identify the source, to
				determine the number of persons exposed to the source, to interview potentially
				exposed persons, to collect and submit clinical and environmental samples for
				laboratory testing and to determine the need to institute measures to control
				the outbreak or suspected outbreak.
3. The owner, manager or any other person in
				charge of a food establishment shall promptly cooperate with the health
				authority in all matters relating to the investigation of a foodborne disease
				outbreak, including, but not limited to:
(a)
				Providing information, including names and addresses of patrons and employees,
				work schedules of employees, histories of illnesses of employees, menus and any
				other information requested by the health authority.
(b) Providing access to employees for
				interviewing and obtaining clinical specimens.
(c) Providing food, beverage and
				environmental samples for laboratory testing.
(d) Cooperating with the efforts of the
				health authority to carry out procedures for the prevention, suppression and
				control of the foodborne disease outbreak, including, without limitation,
				procedures of exclusion, isolation and quarantine.
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.540 - Gonococcal infection

Current through June 11, 2024
1. The health
				authority shall investigate each report of a case having gonococcal infection
				to confirm the diagnosis, to determine the source or possible source of the
				infection and to ensure that the case and any contacts have received
				appropriate testing and medical treatment for the infection.
2. Except as otherwise provided in
				NRS
				441A.210, a person having gonococcal
				infection shall obtain medical treatment for the infection.
3. The health care provider for a person with
				gonococcal infection shall notify the health authority immediately if the
				person fails to obtain medical treatment or fails to complete the prescribed
				course of medical treatment. Except as otherwise provided in
				NRS
				441A.210, the health authority shall take
				action to ensure that the person receives appropriate medical treatment for the
				infection.
4. A clinic, dispensary
				or health care provider that accepts supplies or aid from the Division shall
				provide counseling and take such measures for the testing, treatment,
				prevention, suppression and control of gonococcal infection as are specified in
				"Sexually Transmitted Infections Treatment Guidelines, 2021," adopted by
				reference pursuant to NAC
				441A.200.
5. A health care provider shall follow the
				procedures set forth in "Sexually Transmitted Infections Treatment Guidelines,
				2021," adopted by reference pursuant to NAC
				441A.200, when testing and
				treating persons with gonococcal infection.
6. If a neonatal case having gonococcal
				infection is in a medical facility, the medical facility shall provide care to
				the case in accordance with contact isolation or other appropriate disease
				specific precautions.
Added to NAC by Bd. of
				  Health, eff. 1-24-92; A by R087-08, 1-13-2011; A by
				  R148-22A,
				  eff. 7/26/2023; A by
				  R002-22A,
				  eff. 9/18/2023
NRS 439.200,
					 441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.545 - Granuloma inguinale

Current through June 11, 2024
1. The health
				authority shall investigate each report of a case having granuloma inguinale to
				confirm the diagnosis, to determine the source or possible source of the
				infection and to ensure that the case and any contacts have received
				appropriate testing and medical treatment for the disease.
2. Except as otherwise provided in
				NRS
				441A.210, a person with granuloma inguinale
				shall obtain medical treatment for the disease.
3. The health care provider for a person with
				granuloma inguinale shall notify the health authority immediately if the person
				fails to submit to medical treatment or fails to complete the prescribed course
				of medical treatment. Except as otherwise provided in
				NRS
				441A.210, the health authority shall take
				action to ensure that the person receives appropriate medical treatment for the
				disease.
4. A clinic, dispensary or
				health care provider that accepts supplies or aid from the Division shall
				provide counseling and take such measures for the testing, treatment,
				prevention, suppression and control of granuloma inguinale as are specified in
				"Sexually Transmitted Infections Treatment Guidelines, 2021," adopted by
				reference pursuant to NAC
				441A.200.
5. A health care provider shall follow the
				procedures set forth in "Sexually Transmitted Infections Treatment Guidelines,
				2021," adopted by reference pursuant to NAC
				441A.200, when testing and
				treating persons with granuloma inguinale.
Added to NAC by Bd. of
				  Health, eff. 1-24-92; A by R087-08, 1-13-2011; A by
				  R148-22A,
				  eff. 7/26/2023; A by
				  R002-22A,
				  eff. 9/18/2023
NRS 439.200,
					 441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.550 - Haemophilus influenzae type b

Current through June 11, 2024
1. The health
				authority shall investigate each report of a case having an invasive disease
				caused by
Haemophilus influenzae
type b, which includes
				bacteremia, meningitis, epiglottitis, septic arthritis, cellulitis,
				pericarditis, endocarditis, osteomyelitis and pneumonia, to:
(a) Confirm the diagnosis;
(b) Determine the extent of any
				outbreak;
(c) Determine if the case
				is a child attending a child care facility; and
(d) Identify any contacts and determine the
				need for antimicrobial prophylaxis of any contacts.
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.555 - Hansen's disease (leprosy)

Current through June 11, 2024
1. The health
				authority shall investigate each report of a case having Hansen's disease
				(leprosy) to confirm the diagnosis and to identify any contacts residing in the
				same household as the case.
2. A
				contact residing in the same household as a case having Hansen's disease
				(leprosy) shall obtain an examination by a physician for signs of the disease
				as soon as possible after diagnosis of the index case, and at 6- to 12-month
				intervals for not less than 5 years after his or her last contact with the case
				while infectious.
Added to NAC by Bd. of
				  Health, eff. 1-24-92; A by R087-08, 1-13-2011
NRS
					 441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.557 - Hantavirus infection

Current through June 11, 2024
1. The health
				authority shall investigate each report of:
(a) A case having a hantavirus infection, as
				identified by serological testing for hantaviral antibodies,
				immunohistochemistry studies, polymerase chain reaction studies or other
				appropriate laboratory studies; and
(b) A suspected case having a hantavirus
				infection, as identified by the presence of symptoms consistent with hantavirus
				pulmonary syndrome.
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.565 - Hepatitis A: Presence of case in child care facility

Current through June 11, 2024
1. If a case having hepatitis A is an
				employee or a child in a child care facility and there are no children in
				diapers in the child care facility, the health authority shall offer
				appropriate prophylaxis to all employees and children in contact with the case
				and who have not been vaccinated against hepatitis A.
2. The health authority shall offer
				appropriate prophylaxis to all employees and enrolled children in a child care
				facility who have not been vaccinated against hepatitis A if a child in diapers
				is enrolled in the child care facility and:
(a) A case having hepatitis A is an employee
				or a child in the child care facility; or
(b) A case having hepatitis A has occurred in
				the households of two or more children in the child care facility.
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.570 - Hepatitis B, C and Delta

Current through June 11, 2024
1. The health
				authority shall investigate each report of:
(a) An acute case of hepatitis B, C or Delta;
				or
(b) A pregnant woman who is
				positive for hepatitis B surface antigen upon testing of a blood specimen by a
				medical laboratory, to confirm the diagnosis, to identify any carriers or other
				cases, to identify the contacts of the case, to identify the source of the
				infection and to determine the need for postexposure prophylaxis for the
				contacts.
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.572 - Hepatitis E

Current through June 11, 2024
1. The health authority shall investigate
				each report of a case having hepatitis E to confirm the diagnosis, identify any
				contacts or other cases, determine the extent of any outbreak, identify the
				source of the infection and determine if the case is employed in a sensitive
				occupation or is a child attending a school or child care facility.
2. Except as otherwise provided in this
				subsection, a case having hepatitis E shall not work in a sensitive occupation
				, unless the employer of the case would be prohibited from preventing the
				person from engaging in that occupation by the Americans with Disabilities Act
				of 1990, 42 U.S.C.
				§§
										12101 et seq., or
				NRS
				613.330. The health authority may waive the
				provisions of this subsection if a case is considered not to be
				infectious.
3. The health authority
				shall instruct cases having hepatitis E of the need for and proper method of
				hand washing after defecation.
Added to NAC by Bd. of
				  Health by R087-08, eff. 1-13-2011; A by
				  R148-22A,
				  eff. 7/26/2023
NRS 439.200,
					 441A.120,
					 441A.180
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.574 - Hepatitis, unspecified

Current through June 11, 2024
1. The health
				authority shall investigate each report of a case having acute unspecified
				hepatitis to determine the cause of the hepatitis.
2. If the health authority determines that
				the hepatitis is caused by the:
(a) Hepatitis
				A virus, the health authority shall take further action, as appropriate,
				pursuant to NAC 441A.560 and 441A.565;
(b) Hepatitis B, C or Delta virus, the health
				authority shall take further action pursuant to NAC 441A.570; or
(c) Hepatitis E virus, the health authority
				shall take further action pursuant to NAC 441A.572.
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.575 - Influenza

Current through June 11, 2024
1. The health authority shall:
(a) For purposes of surveillance and
				reporting, obtain sufficient information of each:
(1) Case having influenza that:
(I) Results in hospitalization and is
				confirmed by a laboratory; or
(II)
				Is of a viral strain that the Centers for Disease Control and Prevention or the
				World Health Organization has determined poses a risk of a national or global
				pandemic; or
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.580 - Legionellosis

Current through June 11, 2024
1. The health authority shall investigate
				each report of a case having legionellosis to confirm the diagnosis and to
				gather information for the case report.
2. If two or more cases having legionellosis
				occur among associated persons, the health authority shall investigate to
				determine the extent of the outbreak and to identify a common environmental
				source.
Added to NAC by Bd. of
				  Health, eff. 1-24-92
NRS
					 441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.585 - Leptospirosis

Current through June 11, 2024
1. The health authority shall investigate
				each report of a case having leptospirosis to confirm the diagnosis, to
				identify any contacts, carriers or other cases and to identify the source of
				the infection.
2. If the source of
				infection is suspected to be an infected animal, environmental contamination or
				occupational exposure, the health authority shall notify the State Health
				Officer. The State Health Officer shall notify the appropriate regulatory
				agency responsible for controlling the source of the disease.
3. If a case having leptospirosis is in a
				medical facility, the medical facility shall provide care to the case in
				accordance with universal precautions or other appropriate disease specific
				precautions.
Added to NAC by Bd. of
				  Health, eff. 1-24-92
NRS
					 441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.590 - Listeriosis

Current through June 11, 2024
1. The health authority shall investigate
				each report of a case having listeriosis to confirm the diagnosis, to identify
				any carriers or other cases, to identify the source of the infection and to
				determine if there is an outbreak.
2. If the source of infection is suspected to
				be an infected animal, a contaminated product or an occupational exposure, the
				health authority shall notify the State Health Officer. The State Health
				Officer shall notify the appropriate regulatory agency responsible for
				controlling the source of the disease.
Added to NAC by Bd. of
				  Health, eff. 1-24-92
NRS
					 441A.120
Nevada Administrative Code › Chapter 441A - INFECTIOUS DISEASES; TOXIC AGENTS › INVESTIGATING, REPORTING, PREVENTING, SUPPRESSING AND CONTROLLING PARTICULAR COMMUNICABLE DISEASES › Miscellaneous Communicable Diseases › Section 441A.595 - Lyme disease

Current through June 11, 2024
The health authority shall investigate each report of a case
				  having Lyme disease, as identified by finding the infections agent in a
				  clinical specimen through testing by a medical laboratory, to:
1. Confirm the diagnosis;
2. Determine the extent of any
				outbreak;
3. Identify the source of
				the infection; and
4. Determine the
				necessity of initiating measures for the control of vectors.
Added to NAC by Bd. of
				  Health, eff. 1-24-92; A by
				  R148-22A,
				  eff. 7/26/2023
NRS 439.200,
					 441A.120